University of Glasgow scientists headed by Professor Peter Kennedy, have produced a new pill to treat sleeping sickness that avoids the risks of death caused by conventional intravenous drugs
Researchers in the University's Institute of Infection, Immunity & Inflammation have created a safer version of the drug by combining melarsoprol with cyclodextrins molecules that surround it. This allows the treatment to be administered orally which increases the drugs solubility
and releases it more slowly in the gut.
Read published article